TNFα treatment caused insulin resistance as indicated by a 44% reduction in insulin-stimulated 2DOG uptake (Fig. 5H), loss of GLUT4 (−48%, Fig. 5I), and reduced insulin-regulated AKT phosphorylation (−54%, Fig. 5K). The gene discussed is AKT1; the disease is Insulin resistance.